Stage IIIA Gallbladder Cancer

7 clinical trials · Condition

Record	Firm	Date
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896)	University of Southern California	2015-09-03
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer (NCT02333188)	University of Chicago	2014-12-01
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery (NCT02042443)	National Cancer Institute (NCI)	2014-02-01
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603)	University of Nebraska	2013-04-09
Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery (NCT01859182)	National Cancer Institute (NCI)	2013-01-01
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer (NCT00075504)	National Cancer Institute (NCI)	2003-11-01

Every clearance here is in the API, with alerts when new ones post.